跳至主要内容
临床试验/JPRN-UMIN000008753
JPRN-UMIN000008753已完成4 期

Effect of febuxisostat on serum uric acid levels and endothelial function in patients with hyperuricemia - Effect of febuxisostat on serum uric acid levels and endothelial function in patients with hyperuricemia

Department of Cardiovascular Medicine, Juntendo University School of Medicine0 个研究点目标入组 10 人开始时间: 2012年9月1日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
10

研究概览

简要总结

/A

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Patients who have contraindication of febuxostat treatment. 2) Patients with secondary hyperuricemia. 3) Patient who have systolic blood pressure of 160mmHg or higher, or diastolic blood pressure of 100mgHg or higher. 4) Patients with AST and ALT elevation more than twice the institutional standard. 5) Patients who have had coronary heart disease and cerebrovascular disease within 6 months. 6) Patients treated with mercaptopurine hydrate or azathioprine 7) Breast-feeding woman 8) Patients judged to be unsuitable participants by physician-in-charge

研究者

发起方
Department of Cardiovascular Medicine, Juntendo University School of Medicine

相似试验